Position in LH
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,318,800
+$107,483 QoQ
Shares Held
4,710
+3.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#418
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $29,458,406 across 29 Diagnostics & Research names. LH ranks #4 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
37,694 | $18,898,263 | |
| 2 | DHR |
Danaher Corp /De/
|
13,827 | $2,633,766 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,718 | $1,430,863 | |
| 4 | LH |
Labcorp Holdings Inc.
This page
|
4,710 | $1,318,800 | |
| 5 | A |
Agilent Technologies, Inc.
|
6,947 | $922,770 | |
| 6 | DGX |
Quest Diagnostics Inc
|
4,006 | $849,071 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
3,441 | $664,870 | |
| 8 | WAT |
Waters Corp /De/
|
1,309 | $490,927 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,318,800 | 4,710 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,211,317 | 4,540 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,020,328 | 4,067 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $965,382 | 3,363 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $897,521 | 3,419 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $690,306 | 2,966 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $321,506 | 1,402 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $326,504 | 1,461 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $338,437 | 1,663 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||